| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |